Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Saúde e Pesquisa (Online) |
Texto Completo: | https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133 |
Resumo: | Systemic Arterial Hypertension (SAH) is a multifactorial clinical condition with non-pharmacological and/or pharmacological treatment that requires pharmacotherapeutic monitoring in order to manage the health condition. The objective was to evaluate the impact of a pharmacotherapeutic follow-up program of patients with SAH through a quasi-experimental, longitudinal, and prospective study. Twenty-eight patients were evaluated, 50% of which had decompensated blood pressure; the DRPs identified were drug interactions (57.1%), pharmacotherapeutic duplication (28.8%), potentially inappropriate medication use in older adults (38.5%), and non-adherence to treatment (89.3%). Of the NOM identified (Negative Outcomes associated with Medication), 56.2% were related to safety, and 37.5% to effectiveness. After the follow-up, 56.3% of the NOM were resolved, 57.1% of patients adhered to treatment, and there was a reduction in the Systolic Blood Pressure (p = 0.010) and Diastolic Blood Pressure (p = 0.020). The program proved to be efficient in reducing systemic blood pressure and resolving DRPs and NOM. |
id |
CESUMAR-1_fce0b0d160138f8f290dc522d9eaa270 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/9133 |
network_acronym_str |
CESUMAR-1 |
network_name_str |
Saúde e Pesquisa (Online) |
repository_id_str |
|
spelling |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertensionEfeito de um programa de acompanhamento farmacoterapêutico em pacientes com hipertensão arterial sistêmicaOutcome and process assessment (Health Care)Pharmaceutical servicesSystemic arterial hypertensionAvaliação de processos e resultados (Cuidados de Saúde)Cuidados farmacêuticosHipertensão arterial sistêmicaHipertensãoacompanhamento farmacoterapêuticoSystemic Arterial Hypertension (SAH) is a multifactorial clinical condition with non-pharmacological and/or pharmacological treatment that requires pharmacotherapeutic monitoring in order to manage the health condition. The objective was to evaluate the impact of a pharmacotherapeutic follow-up program of patients with SAH through a quasi-experimental, longitudinal, and prospective study. Twenty-eight patients were evaluated, 50% of which had decompensated blood pressure; the DRPs identified were drug interactions (57.1%), pharmacotherapeutic duplication (28.8%), potentially inappropriate medication use in older adults (38.5%), and non-adherence to treatment (89.3%). Of the NOM identified (Negative Outcomes associated with Medication), 56.2% were related to safety, and 37.5% to effectiveness. After the follow-up, 56.3% of the NOM were resolved, 57.1% of patients adhered to treatment, and there was a reduction in the Systolic Blood Pressure (p = 0.010) and Diastolic Blood Pressure (p = 0.020). The program proved to be efficient in reducing systemic blood pressure and resolving DRPs and NOM.A Hipertensão Arterial Sistêmica (HAS) é uma condição clínica multifatorial, com tratamento não-farmacológico e/ou farmacológico, que necessita de acompanhamento farmacoterapêutico para gestão da condição de saúde. O objetivo foi avaliar o impacto de um programa de acompanhamento farmacoterapêutico em pacientes com HAS, através do estudo quase-experimental, longitudinal e prospectivo. Foram avaliados 28 pacientes, 50% estavam com pressão arterial descompensada, os PRM (Problemas Relacionados à Medicamentos) identificados foram interações medicamentosas (57,1%), duplicidade farmacoterapêutica (28,8%), medicamentos potencialmente inapropriados para idosos (38,5 %) e não adesão ao tratamento (89,3%). Dos RNM (Resultado Negativos associados à Medicação) 56,2% relacionavam-se à segurança e 37,5% à efetividade. Após o acompanhamento, 56,3% dos RNM foram resolvidos, 57,1% dos pacientes aderiram ao tratamento e houve redução da Pressão Arterial Sistólica (p=0,010) e Pressão Arterial Diastólica (p=0,020). O programa mostrou-se favorável na redução da pressão arterial sistêmica e resolução dos PRM e RNM.Universidade Cesumar - UniCesumar2021-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado por Paresapplication/pdfapplication/pdfhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/913310.17765/2176-9206.2021v14Supl.1.e9133Saúde e Pesquisa; Vol 14 No (Supl. 1) (2021): Supl. 1 - dez. ; 1-14Saúde e Pesquisa; v. 14 n. (Supl. 1) (2021): Supl. 1 - dez. ; 1-142176-9206reponame:Saúde e Pesquisa (Online)instname:Cesumar Diretoria de Pesquisainstacron:CESUMARporenghttps://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133/6905https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133/6906Marques, Lais Alves Souza, Cristina da SilvaViana, Lorrany Mayandra Leite Souto Oliveira, Izabel Luiza BatistaSantos, Yane Silva Araújo, Tiago Ferreira da SilvaSilva, Daniel Tenório da info:eu-repo/semantics/openAccess2022-08-18T18:21:47Zoai:ojs.pkp.sfu.ca:article/9133Revistahttps://periodicos.unicesumar.edu.br/index.php/saudpesqPUBhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/oainaep@cesumar.br2176-92061983-1870opendoar:2022-08-18T18:21:47Saúde e Pesquisa (Online) - Cesumar Diretoria de Pesquisafalse |
dc.title.none.fl_str_mv |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension Efeito de um programa de acompanhamento farmacoterapêutico em pacientes com hipertensão arterial sistêmica |
title |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension |
spellingShingle |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension Marques, Lais Alves Outcome and process assessment (Health Care) Pharmaceutical services Systemic arterial hypertension Avaliação de processos e resultados (Cuidados de Saúde) Cuidados farmacêuticos Hipertensão arterial sistêmica Hipertensão acompanhamento farmacoterapêutico |
title_short |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension |
title_full |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension |
title_fullStr |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension |
title_full_unstemmed |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension |
title_sort |
Effect of a pharmacotherapeutic follow-up program in patients with systemic arterial hypertension |
author |
Marques, Lais Alves |
author_facet |
Marques, Lais Alves Souza, Cristina da Silva Viana, Lorrany Mayandra Leite Souto Oliveira, Izabel Luiza Batista Santos, Yane Silva Araújo, Tiago Ferreira da Silva Silva, Daniel Tenório da |
author_role |
author |
author2 |
Souza, Cristina da Silva Viana, Lorrany Mayandra Leite Souto Oliveira, Izabel Luiza Batista Santos, Yane Silva Araújo, Tiago Ferreira da Silva Silva, Daniel Tenório da |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Marques, Lais Alves Souza, Cristina da Silva Viana, Lorrany Mayandra Leite Souto Oliveira, Izabel Luiza Batista Santos, Yane Silva Araújo, Tiago Ferreira da Silva Silva, Daniel Tenório da |
dc.subject.por.fl_str_mv |
Outcome and process assessment (Health Care) Pharmaceutical services Systemic arterial hypertension Avaliação de processos e resultados (Cuidados de Saúde) Cuidados farmacêuticos Hipertensão arterial sistêmica Hipertensão acompanhamento farmacoterapêutico |
topic |
Outcome and process assessment (Health Care) Pharmaceutical services Systemic arterial hypertension Avaliação de processos e resultados (Cuidados de Saúde) Cuidados farmacêuticos Hipertensão arterial sistêmica Hipertensão acompanhamento farmacoterapêutico |
description |
Systemic Arterial Hypertension (SAH) is a multifactorial clinical condition with non-pharmacological and/or pharmacological treatment that requires pharmacotherapeutic monitoring in order to manage the health condition. The objective was to evaluate the impact of a pharmacotherapeutic follow-up program of patients with SAH through a quasi-experimental, longitudinal, and prospective study. Twenty-eight patients were evaluated, 50% of which had decompensated blood pressure; the DRPs identified were drug interactions (57.1%), pharmacotherapeutic duplication (28.8%), potentially inappropriate medication use in older adults (38.5%), and non-adherence to treatment (89.3%). Of the NOM identified (Negative Outcomes associated with Medication), 56.2% were related to safety, and 37.5% to effectiveness. After the follow-up, 56.3% of the NOM were resolved, 57.1% of patients adhered to treatment, and there was a reduction in the Systolic Blood Pressure (p = 0.010) and Diastolic Blood Pressure (p = 0.020). The program proved to be efficient in reducing systemic blood pressure and resolving DRPs and NOM. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-12-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado por Pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133 10.17765/2176-9206.2021v14Supl.1.e9133 |
url |
https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133 |
identifier_str_mv |
10.17765/2176-9206.2021v14Supl.1.e9133 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133/6905 https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/9133/6906 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Cesumar - UniCesumar |
publisher.none.fl_str_mv |
Universidade Cesumar - UniCesumar |
dc.source.none.fl_str_mv |
Saúde e Pesquisa; Vol 14 No (Supl. 1) (2021): Supl. 1 - dez. ; 1-14 Saúde e Pesquisa; v. 14 n. (Supl. 1) (2021): Supl. 1 - dez. ; 1-14 2176-9206 reponame:Saúde e Pesquisa (Online) instname:Cesumar Diretoria de Pesquisa instacron:CESUMAR |
instname_str |
Cesumar Diretoria de Pesquisa |
instacron_str |
CESUMAR |
institution |
CESUMAR |
reponame_str |
Saúde e Pesquisa (Online) |
collection |
Saúde e Pesquisa (Online) |
repository.name.fl_str_mv |
Saúde e Pesquisa (Online) - Cesumar Diretoria de Pesquisa |
repository.mail.fl_str_mv |
naep@cesumar.br |
_version_ |
1754122535792803840 |